Related Experiment Videos
[Animal experiments on influencing ischemic myocardial damage following temporary coronary artery ligation]
Abstract:
Ischemic myocardial damage produced by temporary coronary artery occlusion of 60 min duration is diminished by beta-sympathicolytic acting TrasicorR (3 mg per kg) and osmotically cell-dehydrating Manitol (1 g per kg). Trasylol, a proteinases inhibiting substance, caused a favourable effect at very high doses (100 000 DIE per kg) only. The extent and irreversibility of myocardial ischemic damage was determined by experiments of 180 min duration by intravital fluorochromatisation with acrine orange, determination of hydrogen ion concentration at frozen section of heart muscle with pH-indicatorpaper and enzymehistochemical and histochemical methods.
Insights
Beta-sympathicolytic Trasicor and cell-dehydrating Mannitol reduce ischemic myocardial damage. High doses of proteinase inhibitor Trasylol also showed benefits in reducing heart muscle damage.
Area of Science:
- Cardiology
- Pharmacology
- Biochemistry
Context:
- Myocardial ischemia is a significant cause of heart damage.
- Temporary coronary artery occlusion models are used to study ischemic injury.
- Assessing the extent and irreversibility of myocardial damage is crucial for treatment development.
Purpose:
- To evaluate the protective effects of Trasicor (a beta-sympathicolytic) and Mannitol (an osmotic dehydrating agent) on ischemic myocardial damage.
- To investigate the efficacy of Trasylol, a proteinase inhibitor, in mitigating myocardial injury.
- To determine the optimal therapeutic strategies for reducing heart muscle damage during ischemia.
Summary:
- Trasicor (3 mg/kg) and Mannitol (1 g/kg) significantly diminished ischemic myocardial damage caused by 60 minutes of coronary artery occlusion.
- Trasylol demonstrated a favorable effect only at very high doses (100,000 DIE/kg).
- Myocardial damage extent and irreversibility were assessed using intravital fluorochromatisation, pH determination, and enzyme-histochemical methods.
Impact:
- These findings suggest Trasicor and Mannitol as potential therapeutic agents for reducing heart damage during ischemic events.
- The study highlights the dose-dependent efficacy of Trasylol in protecting against myocardial ischemia.
- This research contributes to understanding the mechanisms of myocardial protection and informs future clinical interventions.